A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or without aura, Axsome Therapeutics announced. Meloxicam is a COX-2 preferential ...

Symbravo is not substitutable with other formulations of meloxicam or rizatriptan. The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of ...

The pharmacodynamic properties of meloxicam have been reviewed by various authors, including Noble & Balfour. [16] In this article, we focus on the main studies that have evaluated the affinity of ...

Credit: Shutterstock. The application is supported by data from the phase 3 MOMENTUM and INTERCEPT trials. The Food and Drug Administration has accepted the New Drug Application for AXS-07 for the ...